Impeto Medical is a privately owned medical device company formed in June 2005. Its corporate headquarters are located in Paris, France. Two subsidiaries have been created: Beijing Impeto Medical in China and Impeto Medical Inc. in San Diego, U.S.
Impeto Medical has developed a patented technology that assesses sudomotor function through sweat gland activity. It is non-invasive and analyzes the ability of sweat glands to release chloride ions in response to an electrical stimulus. Sweat conductances are then measured on the palms of the hands and the soles of the feet. The level of sweat gland activity is linked to the status of small nerve fibers innervating sweat glands. Small fiber neuropathy can be present in the early stages of diabetes and prediabetes. The company’s well-proven proprietary technology enables the early detection of neuropathies caused by diabetes complications and when the developing conditions are still reversible. SUDOSCAN provides easy and quantifiable means of monitoring the progression of a patient’s neuropathic complications.
Based on this technology, Impeto Medical has developed SUDOSCAN, a device for the detection and follow-up of peripheral autonomic neuropathies.